drugset / Trial / NCT03152890

Insulin Therapy for Postreperfusion Hyperglycemia

NCT03152890

Phase 4 Unknown 20 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Glycemic control during liver transplantation is challenging especially after reperfusion of the liver graft. Insulin dose to treat postreperfusion hyperglycemia is retrospectively analyzed using historical data. The proposed dose then is prospectively applied to the patients to assess the adequacy of the insulin dose.

Timeline

Start
2017-05-15
Primary completion
2024-12-15
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic

Indications